ProShare Advisors LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$265,840
-25.7%
17,162
-23.6%
0.00%0.0%
Q1 2024$357,965
+13.0%
22,457
+19.2%
0.00%0.0%
Q4 2023$316,751
+77.3%
18,843
+23.3%
0.00%0.0%
Q3 2023$178,611
-11.9%
15,279
+1.3%
0.00%0.0%
Q2 2023$202,769
-12.8%
15,087
+7.5%
0.00%0.0%
Q1 2023$232,634
-18.1%
14,031
-8.1%
0.00%0.0%
Q4 2022$284,096
+68.1%
15,274
+15.3%
0.00%0.0%
Q3 2022$169,000
+125.3%
13,247
+23.1%
0.00%
Q2 2022$75,000
-50.3%
10,763
-40.9%
0.00%
Q1 2022$151,000
+5.6%
18,208
-14.2%
0.00%
Q4 2021$143,000
+116.7%
21,216
+70.5%
0.00%
Q3 2021$66,000
-54.5%
12,442
-50.6%
0.00%
Q2 2021$145,000
+20.8%
25,190
-2.9%
0.00%
Q1 2021$120,000
+66.7%
25,933
+20.6%
0.00%
Q4 2020$72,000
+105.7%
21,506
+80.7%
0.00%
Q3 2020$35,000
-42.6%
11,900
-9.8%
0.00%
Q2 2020$61,000
+24.5%
13,191
+0.9%
0.00%
Q4 2019$49,000
-15.5%
13,078
+19.0%
0.00%
Q3 2019$58,000
+48.7%
10,989
+7.6%
0.00%
Q2 2019$39,000
-26.4%
10,214
-2.6%
0.00%
Q1 2019$53,000
+165.0%
10,487
+3.2%
0.00%
Q4 2018$20,000
-55.6%
10,161
-13.9%
0.00%
Q3 2018$45,000
+12.5%
11,801
-7.1%
0.00%
Q2 2018$40,000
+48.1%
12,705
+13.6%
0.00%
Q1 2018$27,000
-35.7%
11,184
+5.3%
0.00%
Q4 2017$42,000
+55.6%
10,620
-3.2%
0.00%
Q4 2015$27,00010,9660.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders